SCHEMBL28958730

SCHEMBL28958730

O=C(NCCCc1ccccc1)c1ccc(Cl)o1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.74
HPGD P15428 7/20 0.74
ALDH1A1 P00352 4/20 0.74
L3MBTL1 Q9Y468 2/20 0.68
GLA P06280 1/20 0.68
RAB9A P51151 5/20 0.61
MAPT P10636 2/20 0.56
POLB P06746 2/20 0.56
TSHR P16473 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NLRP1 Q9C000 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
GAA P10253 1/20 0.53
HSP90AA1 P07900 1/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28958706 0.96 HPGD (0.75) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL28958700 0.91 ALDH1A1 (0.73) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL28958702 0.81 HPGD (0.71) HPGDALDH1A1RAB9AMAPTPOLB
SCHEMBL30865543 0.79 NPC1 (0.79) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL28958744 0.79 MAPT (0.61) NPC1HPGDALDH1A1RAB9AMAPT
SCHEMBL30954338 0.78 L3MBTL1 (0.71) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL22546922 0.77 HPGD (0.53) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL3225126 0.76 NPC1 (1.00) NPC1HPGDALDH1A1L3MBTL1RAB9A
SCHEMBL31337274 0.76 HPGD (1.00) NPC1HPGDALDH1A1L3MBTL1GLA
SCHEMBL17510994 0.75 HIF1A (0.67) NPC1ALDH1A1RAB9AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115707699-A Anti-osteoporosis compound and application thereof 中国医学科学院医药生物技术研究所 2023-02-21 CN disclosed